Khalid Islam Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

PCSA Quotes by TradingView

Khalid Islam is Director of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 72,486 shares of PCSA, which is worth approximately $98,580. The most recent transaction as insider was on Mar 31, 2022, when has been sold 4,392 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.5K
0% 3M change
0% 12M change
Total Value Held $98,580

Khalid Islam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
BUY
Grant, award, or other acquisition
-
4,392 Added 5.71%
72,486 Common Stock

Also insider at

IMMU
IMMUNOMEDICS INC
Director
FENC
FENNEC PHARMACEUTICALS INC. Healthcare
GANX
Gain Therapeutics, Inc. Healthcare
Executive Chairman
KI

Khalid Islam

Director
Bethesda, MD

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCSA